Your CRDMO Partner in Science
Author Archives: Jubilantbiosys
Jubilant Biosys Limited to add Drug Discovery & Preclinical Development capabilities in Biologics and Antibody Drug Conjugate
Jubilant Biosys announce strategic joint venture with Pierre Fabre to acquire its R&D centre in France, to enter into Biologics (mABs) and ADCs
Syngeneic Models: A Powerful Tool for Evaluating Immuno-Oncology Drugs for Cancer Therapy
A proud moment for Jubilant Biosys !!
Our partner ‘Inipharm’ has announced the initiation of clinical trials with a compound that was discovered at our integrated drug discovery site, Bengaluru.
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Authors: Sven Ruf, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur, Mahanandeesha S. Hallur, Shilpa Rani, Rajendra Kristam, Srinivasan Swaminathan, Bharat Ravindra Zope, Pavan Kumar Gondrala, Indu Swamy, V. P. Rama Kishore Putta, Saravanan Kandan, Gernot Zech, Herman Schreuder, Christine Rudolph, Ralf Elvert, Joerg Czech, Swarnakumari Birudukota, M. Amir Siddiqui, Niranjan Naranapura Anand, Vishal Subhash Mane, Sreekanth Dittakavi, […]
Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics.
Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.